CytRx Corporation (CYTR) to Hold Conference Call Today at 10:00 a.m. Eastern Time to Discuss Favorable Results from INNO-206 Clinical Trial in Soft Tissue Sarcoma

6/4/2012 10:32:46 AM

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, will hold a conference call to discuss favorable clinical results from the Phase 1b/2 clinical trial with INNO-206 in patients with advanced soft tissue sarcoma and next steps for the INNO-206 program in this indication.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• CytRx Corporation

• Biotech/Pharma - Events

• Biotech/Pharma - Industry